1 December 2023
- 21:4121:41, 1 December 2023 diff hist −50 Patient Association: Lymphedema Rhône-Alpes (France) No edit summary
- 21:4121:41, 1 December 2023 diff hist −50 Patient Association: Les Mutilés de la voix (France) No edit summary
- 21:4121:41, 1 December 2023 diff hist −42 Patient Association: The IAS du Lyonnais (France) No edit summary
- 21:4121:41, 1 December 2023 diff hist −38 Patient Association: Vivre comme avant (France) No edit summary
- 21:4121:41, 1 December 2023 diff hist −30 Patient Association: Belle et Bien (France) No edit summary
- 21:4121:41, 1 December 2023 diff hist −92 Patient Association: ELLyE - Ensemble Leucémies Lymphomas Espoir (France) No edit summary
- 21:4021:40, 1 December 2023 diff hist −98 Patient Association: The Léon Bérard Center Volunteers Association (France) No edit summary
- 21:3921:39, 1 December 2023 diff hist −67 Report: EU Country Cancer Profile 2023 (France) No edit summary
- 21:3921:39, 1 December 2023 diff hist −57 Report: Cancer Panorama in France (France) No edit summary
- 21:3921:39, 1 December 2023 diff hist −49 Report: CNAM Studies and Data (France) No edit summary
- 21:3921:39, 1 December 2023 diff hist +45 Guideline: Institut National du Cancer Guidelines (France) No edit summary
- 21:3821:38, 1 December 2023 diff hist −50 Database: Death registry (CepiDC) (France) No edit summary
- 21:3821:38, 1 December 2023 diff hist −138 Database: National data on health insurance expenditure for community care (France) No edit summary
- 21:3721:37, 1 December 2023 diff hist −178 Database: Regional database on hospital prescriptions for drugs delivered in towns (France) No edit summary
- 21:3721:37, 1 December 2023 diff hist −194 Database: Complete database on hospital prescriptions for drugs delivered in the community (France) No edit summary
- 21:3721:37, 1 December 2023 diff hist −114 Database: Additional databases on drug expenditure (France) No edit summary
- 21:3721:37, 1 December 2023 diff hist −108 Database: Complete database on drug expenditure (France) No edit summary
- 21:3721:37, 1 December 2023 diff hist −182 Database: Data by CPAM on health insurance expenditure relating to private health establishments (France) No edit summary
- 21:3521:35, 1 December 2023 diff hist −132 Database: Complete Database on Health Insurance Expenditure (France) No edit summary
- 21:3421:34, 1 December 2023 diff hist −110 Database: Echantillon généraliste de bénéficiaires (EGB) (France) No edit summary
- 21:3321:33, 1 December 2023 diff hist −24 Database: SNIIRAM (France) No edit summary
- 21:3221:32, 1 December 2023 diff hist +88 Healthcare System (France) No edit summary
- 21:3121:31, 1 December 2023 diff hist +62 Service: Sexual Counseling (Oulu University Hospital) No edit summary
- 21:3121:31, 1 December 2023 diff hist +62 Service: Rehabilitation Instructor (Oulu University Hospital) No edit summary
- 21:3121:31, 1 December 2023 diff hist +62 Service: Psychological Support (Oulu University Hospital) No edit summary
- 21:3121:31, 1 December 2023 diff hist +62 Service: Parenting Support (Oulu University Hospital) No edit summary
- 21:3021:30, 1 December 2023 diff hist +62 Novel Therapies and Diagnostic Methods (Oulu University Hospital) No edit summary
- 21:3021:30, 1 December 2023 diff hist +63 Training: General Medicine Training Calendar and Materials (Oulu University Hospital) No edit summary
- 21:2921:29, 1 December 2023 diff hist +63 Experts (Oulu University Hospital) No edit summary
- 21:2921:29, 1 December 2023 diff hist +25 Oulu University Hospital →Trials (Oulu University Hospital)
- 21:2821:28, 1 December 2023 diff hist +95,948 N Trials (Oulu University Hospital) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Oulu University Hospital page '''NCTID''': NCT04607421 '''Title''': A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer '''Study Summary''': The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal c..."
- 21:2721:27, 1 December 2023 diff hist −88 Oulu University Hospital →Trials
- 21:2621:26, 1 December 2023 diff hist +81 Service: Hospital School (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2521:25, 1 December 2023 diff hist +81 Service: Association of Hospital Clowns (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2521:25, 1 December 2023 diff hist +81 Resource: Trials List (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2521:25, 1 December 2023 diff hist +81 Resource: Parents Resources (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2421:24, 1 December 2023 diff hist +81 Novel Therapies and Diagnostic Methods (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2421:24, 1 December 2023 diff hist +82 Training: Professional Training (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2421:24, 1 December 2023 diff hist +82 Experts (Cancer Center of Kuopio University Hospital) No edit summary
- 21:2321:23, 1 December 2023 diff hist +25 Cancer Center of Kuopio University Hospital →Trials (Cancer Center of Kuopio University Hospital)
- 21:2221:22, 1 December 2023 diff hist +42,128 N Trials (Cancer Center of Kuopio University Hospital) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Center of Kuopio University Hospital page '''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''':..."
- 21:2121:21, 1 December 2023 diff hist −88 Cancer Center of Kuopio University Hospital →Trials
- 21:2021:20, 1 December 2023 diff hist +84 Novel Therapies and Diagnostic Methods (TAYS Cancer Centre Tampere University Hospital) No edit summary
- 21:1921:19, 1 December 2023 diff hist +85 Education: Tampere Surgical Education Centre (TSEC) (TAYS Cancer Centre Tampere University Hospital) No edit summary
- 21:1921:19, 1 December 2023 diff hist +85 Experts (TAYS Cancer Centre Tampere University Hospital) No edit summary
- 21:1821:18, 1 December 2023 diff hist +25 TAYS Cancer Centre Tampere University Hospital →Trials (TAYS Cancer Centre Tampere University Hospital)
- 21:1721:17, 1 December 2023 diff hist +6,201 N Trials (TAYS Cancer Centre Tampere University Hospital) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to TAYS Cancer Centre Tampere University Hospital page '''NCTID''': NCT04736706 '''Title''': A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) '''Study Summary''': The goal of..."
- 21:1721:17, 1 December 2023 diff hist −88 TAYS Cancer Centre Tampere University Hospital →Trials
- 21:1521:15, 1 December 2023 diff hist +100 EHDEN Participation (Turku University Hospital Cancer Centre) No edit summary
- 21:1421:14, 1 December 2023 diff hist +77 Resource: Trials List (Turku University Hospital Cancer Centre) No edit summary
